Home › Funds › BCK CAPITAL MANAGEMENT LP › APLS

BCK CAPITAL MANAGEMENT LP position in APLS

APELLIS PHARMACEUTICALS INC

BCK CAPITAL MANAGEMENT LP reported holding 8,000 shares of APLS (APELLIS PHARMACEUTICALS INC) in its Q1 2026 13F filing — a position valued at US$322K, representing 1.40% of its reported portfolio and ranking #14 among its reported holdings. BCK CAPITAL MANAGEMENT LP first reported this position in Q1 2026.

Latest position (Q1 2026)8.00K sh
Reported value held$321.84K
Portfolio Weight1.40%
First reportedQ1 2026
Last changeNew
Updated2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

How BCK CAPITAL MANAGEMENT LP's APLS position evolved

BCK CAPITAL MANAGEMENT LP first disclosed a stake in APLS in Q1 2026 at 8,000 shares (US$322K).

Quarter by quarter

QuarterSharesValueChange
Q1 2026 8.00K $321.84K New

About APLS and 13F data

APLS (APELLIS PHARMACEUTICALS INC) is a company whose sector is not yet classified in our data. 2 other funds we track also report a position in APLS. Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding APLS

No other tracked fund reports a position in APLS.

All APLS fund holders →

FAQ

How long has BCK CAPITAL MANAGEMENT LP held APLS?

BCK CAPITAL MANAGEMENT LP has disclosed APLS holdings in 1 of the last 1 reported quarters, going back to Q1 2026.

What is BCK CAPITAL MANAGEMENT LP's current position in APLS?

As of Q1 2026, BCK CAPITAL MANAGEMENT LP holds 8.00K shares of APLS (APELLIS PHARMACEUTICALS INC), valued at $321.84K, representing 1.40% of its reported portfolio and ranking #14.

Has BCK CAPITAL MANAGEMENT LP been buying or selling APLS?

In the latest 13F filing (Q1 2026), BCK CAPITAL MANAGEMENT LP newly opened its position in APLS.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.